<DOC>
	<DOCNO>NCT00220428</DOCNO>
	<brief_summary>The purpose study evaluate safety T-cell vaccination MS patient .</brief_summary>
	<brief_title>T-Cell Vaccination Multiple Sclerosis ( MS )</brief_title>
	<detailed_description>Immunization MS patient irradiate autologous encephalitogenic myelin peptide ( EMP ) specific T-cell line clone . Clinical immunologic neuroradiologic evaluation .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Definite MS ( post criterion ) Relapsing remit primary progressive clinical course . At least one relapse last two year . Disease duration &gt; 1 year Expanded Disability Status Scale ( EDSS ) 06 Brain magnetic resonance imaging ( MRI ) compatible MS Not involve clinical trial No systemic disease Does comply</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2007</verification_date>
	<keyword>T cell</keyword>
</DOC>